24-Month Clinical Outcomes of a Treat-and-extend Regimen with Ranibizumab for Wet Age-Related Macular Degeneration in a Real Life Setting

Athanasios Vardarinos,Nitin Gupta, Raazia Janjua, Abigail Iron,Theo Empeslidis,Konstantinos T. Tsaousis

BMC ophthalmology（2017）

引用 25|浏览3

暂无评分

摘要

To evaluate the clinical effectiveness and analyze the outcomes of a treat-and-extend (T&E) treatment regimen with ranibizumab for wet age-related macular degeneration (ARMD) in real life clinical settings over the first 2 years (24 months) of treatment.

查看译文

关键词

Ranibizumab,Treat and extend,Age related macular degeneration

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要